A rare case of hyporeninemic hypertension: Answers.
作者信息
Mashmoushi Ahmad, Choudhary Abha, Thomas Christie P, Wolf Matthias T F
机构信息
Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pediatric Endocrinology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
出版信息
Pediatr Nephrol. 2021 Mar;36(3):569-573. doi: 10.1007/s00467-020-04667-4. Epub 2020 Jun 30.
Abstract
摘要
相似文献
1
A rare case of hyporeninemic hypertension: Answers.
Pediatr Nephrol. 2021 Mar;36(3):569-573. doi: 10.1007/s00467-020-04667-4. Epub 2020 Jun 30.
2
Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
J Clin Endocrinol Metab. 2015 Jan;100(1):E155-63. doi: 10.1210/jc.2014-3009.
3
KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
J Hypertens. 2018 Mar;36(3):619-627. doi: 10.1097/HJH.0000000000001578.
4
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Clin Exp Pharmacol Physiol. 2013 Dec;40(12):895-901. doi: 10.1111/1440-1681.12151.
5
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.
J Clin Endocrinol Metab. 2015 Jan;100(1):E114-8. doi: 10.1210/jc.2014-3636.
6
Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.
J Clin Endocrinol Metab. 2021 May 13;106(6):1606-1616. doi: 10.1210/clinem/dgab118.
7
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
ANZ J Surg. 2015 Apr;85(4):279-83. doi: 10.1111/ans.12470. Epub 2013 Nov 26.
8
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132. Epub 2016 Jul 12.
9
Familial hyperaldosteronism type III a novel case and review of literature.
Rev Endocr Metab Disord. 2019 Mar;20(1):27-36. doi: 10.1007/s11154-018-9481-0.
10
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
J Clin Endocrinol Metab. 2013 Nov;98(11):E1861-5. doi: 10.1210/jc.2013-2428. Epub 2013 Sep 13.
引用本文的文献
1
A narrative review of Hyporeninemic hypertension-an indicator for monogenic forms of hypertension.
Pediatr Med. 2022 May;5. doi: 10.21037/pm-21-48. Epub 2022 May 28.
本文引用的文献
1
Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.
Nephrol Dial Transplant. 2021 Jan 25;36(2):295-305. doi: 10.1093/ndt/gfz173.
2
Primary Aldosteronism.
Hypertension. 2019 Sep;74(3):458-466. doi: 10.1161/HYPERTENSIONAHA.119.12935. Epub 2019 Jul 22.
3
Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals.
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F146-F158. doi: 10.1152/ajprenal.00288.2018. Epub 2018 Aug 8.
4
CLCN2 chloride channel mutations in familial hyperaldosteronism type II.
Nat Genet. 2018 Mar;50(3):349-354. doi: 10.1038/s41588-018-0048-5. Epub 2018 Feb 5.
5
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.
Elife. 2015 Apr 24;4:e06315. doi: 10.7554/eLife.06315.
6
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.
J Clin Endocrinol Metab. 2015 Jan;100(1):E114-8. doi: 10.1210/jc.2014-3636.
7
The multifaceted mineralocorticoid receptor.
Compr Physiol. 2014 Jul;4(3):965-94. doi: 10.1002/cphy.c130044.
8
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Nat Genet. 2013 Sep;45(9):1050-4. doi: 10.1038/ng.2695. Epub 2013 Aug 4.
9
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Clin Exp Pharmacol Physiol. 2013 Dec;40(12):895-901. doi: 10.1111/1440-1681.12151.
10
Role of KCNJ5 in familial and sporadic primary aldosteronism.
Nat Rev Endocrinol. 2013 Feb;9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11.
Zotero 插件